30 results found.

Cirrhosis of Liver, or Hepatic Encephalopathy Clinical Trial using L-ornithine L-aspartate; Placebo

Dayanand Medical College and Hospital - Recruiting 18 years to 70 years.
- Efficacy of Intravenous 'L-ornithine L-aspartate' in Reversal of Overt Acute Hepatic Encephalopathy in Patients With Liver Cirrhosis: a Prospective, Randomized, Double-blind, Placebo Controlled Trial.
L-ornithine L-aspartate; Placebo

Acute on Chronic Hepatic Failure, Acute Liver Failure, Liver Cirr Clinical Trial using IDN-6556

Conatus Pharmaceuticals Inc. - Recruiting 18 years or older.
- A Placebo-Controlled, Multicenter, Double-Blind, Randomized, Pharmacokinetic and Pharmacodynamic Trial of IDN-6556 in Subjects With Acute-on-Chronic Liver Failure.
IDN-6556

Status; Splenectomy Clinical Trial using Desflurane; Propofol

Theodor Bilharz Research Institute - Recruiting 25 years to 55 years.
- Perioperative Effect of Desflurane Versus Total Intravenous Anesthesia With Propofol on Hemostasis Guided by Thromboelastometry in Splenectomy With Liver Cirrhosis..
Desflurane; Propofol

Liver Diseases, Hepatocellular Cancer, Endstage Liver Disease, or Clinical Trial using donor pain management/ Pre-operative OR Set-up

Northwestern University - Recruiting 21 years to 60 years.
- A2ALL-Patients Safety System Improvements in Living Donor Liver Transplant.
donor pain management/ Pre-operative OR Set-up

Liver Cirrhosis, or Portal Vein Thrombosis Clinical Trial

Beijing Friendship Hospital - Recruiting 18 years to 80 years.
- Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis.

Carcinoma, Hepatocellular, Liver Cirrhosis, Alcoholic, Hepatitis, Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 90 years.
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area.

Hepatitis C, Chronic Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- Open-label, Multicenter, Non-comparative, Prospective Observational Study to Evaluate Efficacy and Safety of Combined Ribavirin and Peginterferon Alfa-2a (40 kDa) Therapy in Patients With Chronic Hepatitis C (CHC) and Compensated Liver Cirrhosis in Real Clinical Practice.

Hepatitis B, Cirrhosis, or Awaiting Organ Transplant Clinical Trial using HBV vaccine

Fundaci¢n P£blica Andaluza para la gesti¢n de la Investigaci¢n en Sevilla - Recruiting 18 years to 65 years.
- Open-label, Phase III, Randomized, Clinical Trial to Evaluate the Efficacy of Two Different Hepatitis B Virus (HBV) Vaccination Schemes in Patients With Hepatic Cirrhosis Candidates to Liver Transplantation.
HBV vaccine

Non-Alcoholic Steatohepatitis (NASH) Clinical Trial using Simtuzumab 75 mg; Simtuzumab 125 mg; Placebo

Gilead Sciences - Recruiting 18 years to 60 years.
- A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety, and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like Molecule 2 (LOXL2) in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH).
Simtuzumab 75 mg; Simtuzumab 125 mg; Placebo

Confirmed Diagnosis of HCC;, Patients Who Are Scheduled to Underg Clinical Trial using TACE or Systemic Therapy

Chinese University of Hong Kong - Recruiting 18 years or older.
- A Study to Evaluate the Impact of Liver Stiffness on Treatment Outcome of Unresectable Hepatocellular Carcinoma.
TACE or Systemic Therapy

Acute Bleeding Esophageal Varices, or Liver Cirrhosis Clinical Trial using Hepatic venous pressure gradient measurement

Leiden University Medical Center - Recruiting 18 years to 75 years.
- A Multi-center Randomized Controlled Study of Primary Prevention of Esophageal Variceal Bleeding in Cirrhotic Patients Treated With HVPG-guided Beta- Blocker Therapy or Standard Heart Rate-guided Beta-blocker Therapy.
Hepatic venous pressure gradient measurement

Liver Cirrhosis Clinical Trial

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Recruiting 18 years to 75 years.
- Renal Function Determination With Creatinine and Cystatin C Dependent Formulas Compared to Gold Standard DTPA-TC-99 (Diethylene-triamine-pentaacetate- Technetium-99) in Mexican Cirrhotic Patients.

Liver Cirrhosis Clinical Trial using Placebo; Rifaximin SSD 40 mg IR tablet; Rifaximin SSD 80 mg IR tablet; Rifaximin SSD 40 mg SER tablet; Rifaximin SSD 80 mg SER tablet; Rifaximin SSD 80 mg IR tablet + rifaximin SSD 80 mg SER tablet

Salix Pharmaceuticals - Recruiting 18 years or older.
- A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early Decompensated Liver Cirrhosis.
Placebo; Rifaximin SSD 40 mg IR tablet; Rifaximin SSD 80 mg IR tablet; Rifaximin SSD 40 mg SER tablet; Rifaximin SSD 80 mg SER tablet; Rifaximin SSD 80 mg IR tablet + rifaximin SSD 80 mg SER tablet

Biliary Liver Cirrhosis,, Hemochromatosis, Hepatitis, Hepatolenti Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Evaluation of Patients With Liver Disease.

Liver Cirrhosis Clinical Trial

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico - Recruiting 18 years to 65 years.
- Insulin Secretion and Sensitivity in Subjects With Liver Cirrhosis Undergoing Orthotopic Liver Transplantation (OLT): Pre- and Post-OLT Analysis.

Nonalcoholic Fatty Liver Disease Clinical Trial using MB12066 200mg; Placebo

KT&G Life Sciences Corp - Recruiting 20 years or older.
- A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, 12 Weeks, Therapeutic Exploratory Phase 2 Clinical Study to Evaluate the Safety and Efficacy of MB12066 in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Except Cirrhosis.
MB12066 200mg; Placebo

Cirrhosis, Liver Fibrosis, Portal Hypertension, Cystic Fibrosis, Clinical Trial using Elastometry

Assistance Publique - H“pitaux de Paris - Recruiting 6 Months to 18 years.
- Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of FIBROSCANN..
Elastometry

Liver Cirrhosis, or Ascites Clinical Trial using Body composition in paracentesis

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Recruiting 18 years to 70 years.
- Body Composition Analysis in Cirrhotic Patients With Ascites Treated With Paracentesis.
Body composition in paracentesis

Hepatocellular Carcinoma, or Liver Cirrhosis Clinical Trial using Sirsphere trans-arterial radioembolization

Jules Bordet Institute - Recruiting 18 years or older.
- Treatment With Yttrium90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver.
Sirsphere trans-arterial radioembolization

Liver Cirrhosis, or Ascites Clinical Trial using ALFApump system

Sequana Medical AG - Recruiting 18 years or older.
- Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function in Patients With Cirrhosis and Recurrent or Refractory Ascites.
ALFApump system

Liver Cirrhosis Clinical Trial using entecavir; Thymosin-à

Beijing Friendship Hospital - Recruiting 18 years to 65 years.
- Optimized Treatment and Regression of HBV-induced Early Cirrhosis.
entecavir; Thymosin-à

Cirrhosis Clinical Trial

Sir Ganga Ram Hospital - Recruiting 18 years to 75 years.
- A Prospective Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver Cirrhosis.

Liver Cirrhosis, or Carcinoma, Hepatocellular Clinical Trial

Asan Medical Center - Recruiting 20 years to 80 years.
- Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver: Prospective Pathologic Correlation With Explanted Liver.

Hepatocellular Carcinoma, Liver Cirrhosis, Hepatitis B, or Hepati Clinical Trial using CE-US (SonazoidT); B-mode US

Japan Liver Oncology Group - Recruiting 20 years or older.
- Sonazoid Enhanced Liver Cancer Trial for Early Detection.
CE-US (SonazoidT); B-mode US

Liver Cirrhosis Clinical Trial using Plasma pheresis, Right portal vein embolization

Seoul National University Hospital - Recruiting 20 years to 70 years.
- Evaluation of Liver Regeneration With Autologous Peripheral Stem Cells Transplantation in the Patient Needed Extensive Hepatectomy.
Plasma pheresis, Right portal vein embolization

Normal, Alcoholism, Cirrhosis, or Hepatitis C Clinical Trial using Ultrasound

Temple University - Recruiting 20 years to 70 years.
- Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound..
Ultrasound

Liver Cirrhosis Clinical Trial

National Taiwan University Hospital - Recruiting 50 years to 70 years.
- Functional Genomics and Proteomics Towards and Understanding of Cell Signaling and Diseases--- Genomic and Proteomic Analyses of Liver Cells During Hepatitis Virus Infections and Cell Therapy (4/4).

Liver Diseases, or Cirrhosis Clinical Trial using urotensin II

Bayside Health - Recruiting 18 years to 75 years.
- .
urotensin II

Hepatitis C, Hepatitis B, Autoimmune Hepatitis, Liver Cirrhosis, Clinical Trial

University Health Network, Toronto - Recruiting 18 years to 85 years.
- Differential Gene Expression in Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis With or Without a Complicating Hepatoma or Autoimmune Liver Disease.